Free Float 22,49 %
Shares Float 8,71 M
Shares Outstanding 38,74 M
GeneTether Therapeutics Inc. Share · CA37187D1087 (XCNQ) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of GeneTether Therapeutics Inc.
No Price
Share Float & Liquidity
Company Profile for GeneTether Therapeutics Inc. Share
GeneTether Therapeutics Inc., a genetic medicines company, focuses on developing gene editing therapies to enhance the efficiency of genome editing technologies. It is developing gene therapies for the treatment of patients with rare and monogenic kidney and skin diseases. The company was founded in 2018 and is based in Kelowna, Canada.
Company Data
Name GeneTether Therapeutics Inc.
Company GeneTether Therapeutics Inc.
Website
https://genetether.com
Primary Exchange 
CSE LISTED
CSE LISTED
ISIN CA37187D1087
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Roland Boivin
Country Canada
Currency CAD
Employees -
Address 301 – 1665 Ellis Street, V1Y 2B3 Kelowna
IPO Date 2022-03-30
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | GNTTF |
| CSE LISTED | GTTX.CN |
More Shares
Investors who hold GeneTether Therapeutics Inc. also have the following shares in their portfolio:
